Search

Issue Volume 32(2022)Supplement 2

34. 2022-RA-1020-ESGO Family history in BRCA mutation carriers affected by breast and ovarian cancer and its role in identifying subjects at high risk. (20th October 2022)

Authors:
Negri, Serena; de Ponti, Elena; Sina, Federica Paola; Sala, Elena; Dell'Oro, Cristina; Roversi, Gaia; Lazzarin, Sara; Marchette, Martina Delle; Inzoli, Alessandra; Toso, Claudia; Fumagalli, Simona; Campanella, Ornella; Kotsopoulos, Joanne; Fruscio, Robert
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A378
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

35. 2022-RA-1022-ESGO Implementation of machine learning in a care pathway for advanced epithelial ovarian cancer: a National Cancer Institute experience. (20th October 2022)

Authors:
Boscher, Adrien; Kherbeik, Nour; Craynest, Franck; Hammoudi, Ali; Becourt, Stephanie; Hajj, Houssein El; Martinez-Gomez, Carlos; Narducci, Fabrice; Hudry, Delphine
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

37. 2022-RA-1028-ESGO Role of radiotherapy in platinum sensitive oligometastatic recurrent ovarian cancer: a valid alternative to delay systemic treatment. (20th October 2022)

Authors:
Bonaldo, Giulio; Lazzari, Roberta; Durante, Stefano; Corrao, Giulia; Lapresa, Mariateresa; Parma, Gabriella; Achilarre, Maria Teresa; Aloisi, Alessia; Betella, Ilaria; Garbi, Annalisa; de Vitis, Luigi Antonio; Schivardi, Gabriella; Aletti, Giovanni Damiano; Zanagnolo, Vanna; Maggioni, Angelo; Col...
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

39. 2022-RA-1032-ESGO Evaluation of intraoperative HPV test as an early marker of residual disease after HSIL surgical treatment. a prospective multicenter study. Preliminary results. (20th October 2022)

Authors:
Bradbury, Melissa; Acosta, Ursula; Quesada, Alfonso; Lopez-Fernandez, Jose A; Quilez, Jose; Centeno, Cristina; Gil, Antonio
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A379
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search